Skip to main content
PTC THERAPEUTICS, INC. logo

PTC THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · PTCT ISIN · US69366J2006 LEI · 549300UJLWOIWFDGB318 US Manufacturing
Open in API
Filings indexed 1,161 across all filing types
Latest filing 2020-01-06 Regulatory Filings
Country US United States of America
Listing US PTCT

About PTC THERAPEUTICS, INC.

https://www.ptcbio.com/

PTC Therapeutics, Inc. is a global biopharmaceutical company that discovers, develops, and commercializes clinically differentiated medicines for children and adults with rare and serious diseases. The company focuses on conditions with high unmet medical needs, leveraging its expertise across multiple scientific platforms. These platforms include RNA biology, with a focus on splicing modification to control protein production, and targeting inflammation and ferroptosis pathways for central nervous system diseases. PTC has brought several pioneering treatments to market, including the first approved therapy for Duchenne muscular dystrophy, the first gene therapy administered directly into the brain, and the first small molecule splicing modifier. The company maintains a diversified pipeline of innovative therapies.

Recent filings

Filing Released Lang Actions
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans such as stock option plans. It includes detailed information about inducement stock incentive plans, registration fees, incorporation by reference of other filings, and indemnification provisions for directors and officers. It is not an annual report, earnings release, or any other financial report but a registration statement related to securities issuance under employee plans. Therefore, it fits the category of a regulatory filing related to securities registration under the Securities Act of 1933, which is best classified under Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a proxy statement but a full registration statement filing.
2020-01-06 English
FORM 4
Director's Dealing
2020-01-06 English
FORM 4
Director's Dealing
2019-12-26 English
FORM 4
Director's Dealing
2019-12-05 English
Regulatory Filings 2019
Regulatory Filings
2019-11-07 English
10-Q
Interim / Quarterly Report Q3 2019
2019-10-30 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.